EP 1578927 A2 20050928 - ANTISENSE MODULATION OF NAV1.3 EXPRESSION
Title (en)
ANTISENSE MODULATION OF NAV1.3 EXPRESSION
Title (de)
ANTISENSE-MODULATION DER EXPRESSION VON NAV1.3
Title (fr)
MODULATION ANTISENS DE L'EXPRESSION DE NAV1.3
Publication
Application
Priority
- US 0325465 W 20030814
- US 40341602 P 20020814
Abstract (en)
[origin: WO2004016754A2] Antisense compounds, compositions, and methods are provided for modulating the expression of Type III sodium channel Nav1.3. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Nav1.3. Methods of using these compounds for modulation of Nav1.3 expression and for treatment of diseases associated with expression of Nav1.3 are provided.
IPC 1-7
IPC 8 full level
C12N 15/11 (2006.01); C12N 15/113 (2010.01); A61K 38/00 (2006.01)
CPC (source: EP)
A61P 25/02 (2017.12); A61P 25/04 (2017.12); A61P 25/06 (2017.12); A61P 25/08 (2017.12); A61P 25/18 (2017.12); A61P 43/00 (2017.12); C12N 15/1138 (2013.01); A61K 38/00 (2013.01); C12N 2310/315 (2013.01); C12N 2310/321 (2013.01); C12N 2310/3341 (2013.01); C12N 2310/341 (2013.01); C12N 2310/346 (2013.01); Y02P 20/582 (2015.11)
Citation (search report)
See references of WO 2004016754A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004016754 A2 20040226; WO 2004016754 A3 20051110; AU 2003268096 A1 20040303; AU 2003268096 A8 20040303; BR 0313455 A 20070731; CA 2495398 A1 20040226; EP 1578927 A2 20050928; JP 2006507808 A 20060309; MX PA05001836 A 20050419
DOCDB simple family (application)
US 0325465 W 20030814; AU 2003268096 A 20030814; BR 0313455 A 20030814; CA 2495398 A 20030814; EP 03749047 A 20030814; JP 2004529403 A 20030814; MX PA05001836 A 20030814